It should be noted that targeted approaches with BRAF inhibitors could provide fruitful options in other BRAF V600E mutated brain tumors such as the aggressive or rapidly progressive papillary craniopharyngioma [55] and rhabdoid meningioma meningioma [50]. Here, BRAF is linked to Papillary Craniopharyngioma.